The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: A case series.
作者信息
Ch'en Peter Yi, Farrer Sterling, Miranda-Cacdac Lauren, Song Eingun James
机构信息
Albert Einstein College of Medicine, Bronx, New York.
Silver Falls Dermatology, Salem, Oregon.
出版信息
JAAD Case Rep. 2022 Oct 4;30:1-4. doi: 10.1016/j.jdcr.2022.09.023. eCollection 2022 Dec.
Abstract
摘要
相似文献
1
The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: A case series.白细胞介素23抑制剂在慢性乙型肝炎感染患者中的应用：病例系列
JAAD Case Rep. 2022 Oct 4;30:1-4. doi: 10.1016/j.jdcr.2022.09.023. eCollection 2022 Dec.
2
The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infection.优特克单抗和古塞库单抗在一名患有活动性乙型肝炎感染的儿童银屑病患者中的应用。
JAAD Case Rep. 2020 Dec 14;8:37-39. doi: 10.1016/j.jdcr.2020.12.006. eCollection 2021 Feb.
3
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study.意大利一项为期 28 周的回顾性研究：真实世界中古塞库单抗、里莎鲁单抗和替西珠单抗的间接比较。
J Dermatolog Treat. 2022 Sep;33(6):2813-2820. doi: 10.1080/09546634.2022.2081655. Epub 2022 May 29.
4
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.老年银屑病患者的抗白细胞介素-23 治疗：真实世界中 Guselkumab、Risankizumab 和 Tildrakizumab 的应用。
Clin Exp Dermatol. 2022 Mar;47(3):561-567. doi: 10.1111/ced.14979. Epub 2021 Nov 17.
5
[Expression and significance of interleukin-18, 12 and tumor necrosis factor-α in intrahepatic cholestasis of pregnancy].[白细胞介素-18、12及肿瘤坏死因子-α在妊娠期肝内胆汁淤积症中的表达及意义]
Zhonghua Fu Chan Ke Za Zhi. 2011 May;46(5):329-32.
6
Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis.生物制剂治疗中度至重度斑块状银屑病的疗效和安全性比较：一项多治疗荟萃分析。
J Dtsch Dermatol Ges. 2021 Jan;19(1):47-56. doi: 10.1111/ddg.14308. Epub 2020 Dec 30.
7
From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis.来自国家银屑病基金会医学委员会的建议：对于患有银屑病的患者，在开始使用抗肿瘤坏死因子-α抑制剂或其他免疫抑制剂之前，建议进行乙型肝炎感染筛查。
J Am Acad Dermatol. 2014 Jan;70(1):178-86. doi: 10.1016/j.jaad.2013.08.049. Epub 2013 Nov 9.
8
Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy.抗肿瘤坏死因子-α治疗后乙型肝炎病毒表面抗原阴性慢性乙型肝炎病毒感染者病毒再激活。
J Rheumatol. 2009 Nov;36(11):2416-20. doi: 10.3899/jrheum.081324. Epub 2009 Oct 1.
9
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.管理乙肝或丙肝感染患者的银屑病：实用注意事项。
Am J Clin Dermatol. 2019 Dec;20(6):829-845. doi: 10.1007/s40257-019-00457-3.
10
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence.古塞库单抗、司库奇尤单抗和替拉珠单抗治疗银屑病的真实世界证据综述
Clin Cosmet Investig Dermatol. 2022 Aug 16;15:1649-1658. doi: 10.2147/CCID.S364640. eCollection 2022.
引用本文的文献
1
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection.替拉珠单抗治疗慢性乙型肝炎病毒感染患者的疗效和安全性
Clin Cosmet Investig Dermatol. 2023 Feb 5;16:369-373. doi: 10.2147/CCID.S403294. eCollection 2023.
本文引用的文献
1
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.伴有合并症和特殊人群的中重度银屑病的生物治疗算法：综述。
Am J Clin Dermatol. 2021 Jul;22(4):425-442. doi: 10.1007/s40257-021-00603-w. Epub 2021 Apr 16.
2
The use of ustekinumab and guselkumab in a pediatric psoriasis patient with active hepatitis B infection.优特克单抗和古塞库单抗在一名患有活动性乙型肝炎感染的儿童银屑病患者中的应用。
JAAD Case Rep. 2020 Dec 14;8:37-39. doi: 10.1016/j.jdcr.2020.12.006. eCollection 2021 Feb.
3
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study.生物制剂治疗银屑病患者中乙型和丙型肝炎病毒再激活的预测因素：一项 9 年多中心队列研究。
J Am Acad Dermatol. 2021 Aug;85(2):337-344. doi: 10.1016/j.jaad.2019.12.001. Epub 2019 Dec 9.
4
Hepatitis B: Prevalence, Hope.乙型肝炎：患病率与希望
Ulster Med J. 2019 May;88(2):118-123. Epub 2019 Apr 27.
5
Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections.银屑病：哪种疗法适合哪种患者：关注特殊人群和慢性感染。
J Am Acad Dermatol. 2019 Jan;80(1):43-53. doi: 10.1016/j.jaad.2018.06.056. Epub 2018 Jul 11.
6
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.与免疫抑制及生物调节剂治疗相关的乙型肝炎再激活：当前概念、管理策略及未来方向
Gastroenterology. 2017 May;152(6):1297-1309. doi: 10.1053/j.gastro.2017.02.009. Epub 2017 Feb 20.
7
Management of psoriasis patients with hepatitis B or hepatitis C virus infection.乙型或丙型肝炎病毒感染的银屑病患者的管理。
World J Gastroenterol. 2016 Jul 28;22(28):6444-55. doi: 10.3748/wjg.v22.i28.6444.
8
Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: a review and recommendations for management.银屑病、乙型肝炎和肿瘤坏死因子-α抑制剂：综述与管理建议。
J Am Acad Dermatol. 2012 Dec;67(6):1349-61. doi: 10.1016/j.jaad.2012.04.036. Epub 2012 Jun 21.
Zotero 插件